Dravet Syndrome Ds clinical trials

Explore recruiting dravet syndrome ds clinical trials.

Recruiting dravet syndrome ds studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dravet Syndrome Ds trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants with Dravet Syndrome (ARGUS Trial)

Hungary, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy, Safety, and Tolerability of LP352 in the Treatment of Seizures in Children and Adults with Dravet Syndrome

Latvia, Spain, Portugal, Germany, France, Belgium +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dravet Syndrome Ds trials by city

Dravet Syndrome Ds in Toronto Dravet Syndrome Ds in Vancouver Dravet Syndrome Ds in Montreal Dravet Syndrome Ds in Calgary Dravet Syndrome Ds in Edmonton Dravet Syndrome Ds in Ottawa Dravet Syndrome Ds in Winnipeg Dravet Syndrome Ds in Quebec City Dravet Syndrome Ds in Hamilton Dravet Syndrome Ds in Kitchener Dravet Syndrome Ds in London Dravet Syndrome Ds in Halifax Dravet Syndrome Ds in New York Dravet Syndrome Ds in Los Angeles Dravet Syndrome Ds in Chicago Dravet Syndrome Ds in Houston

Dravet Syndrome Ds clinical trials

Recruiting dravet syndrome ds studies right now

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Also recruiting in Europe

A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Children and Adult Participants with Dravet Syndrome (ARGUS Trial)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy, Safety, and Tolerability of LP352 in the Treatment of Seizures in Children and Adults with Dravet Syndrome

Dravet Syndrome Ds trials by city

Other conditions